Utah Medical Products Inc. reported consolidated earnings results for the fourth quarter and year ended December 31, 2013. For the quarter, the company reported net income of $3,468,000 or $0.917 per share on net sales of $10,085,000 compared to net income of $2,259,000 or $0.606 per share on net sales of $9,832,000 a year ago. Operating income was $3,559,000 compared to $3,570,000 a year ago. Income before tax was $3,485,000 compared to $3,322,000 a year ago.

For the year, the company reported net income of $11,406,000 or $3.022 per share on net sales of $40,493,000 compared to net income of $10,169,000 or $2.740 per share on net sales of $41,552,000 a year ago. Operating income was $14,828,000 compared to $15,196,000 a year ago. Income before tax was $14,476,000 compared to $14,537,000 a year ago. Excluding the noncash effects of depreciation, amortization of intangible assets and non-cash stock option expense and asset impairment expense, 2013 consolidated earnings before taxes plus interest expense were $18,136,000 compared to $18,703,000 in 2012. Non-U.S. GAAP earnings per share (EPS) in 2013 without the $976 tax provision adjustment were $2.76. The non-U.S. GAAP net profit (before applying the $976,000 tax reduction to the provision due to the reduction in the DTL) was $10,430,000 (25.8% of sales) compared to $10,169,000 in 2012.